Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Stock and oil futures start trading ahead of key jobs data and earnings week.

Market News
03 May 2026
Barrons
View Source
Neutral
pluang ai news

Stock and oil futures began trading on Sunday in anticipation of a busy week featuring important earnings reports and major labor market data releases. These events are closely watched by investors as they provide insights into economic health and can influence market direction. The outcomes will likely impact trading strategies and market sentiment throughout the week.

More News

Millions of Americans want jobs but can't find them, surpassing 2008 crisis levels.

Millions of Americans want jobs but can't find them, surpassing 2008 crisis levels.

A recent report reveals that over 6.2 million Americans want jobs but are not actively seeking work, a group known as discouraged or shadow workers. This number has surged by more than 1.2 million since March 2023, exceeding levels seen during the 20...

Market News
Bearish
47 minutes ago
Defiance launches 2X leveraged ETF for SpaceX, highlighting its broad business beyond rockets.

Defiance launches 2X leveraged ETF for SpaceX, highlighting its broad business beyond rockets.

Defiance ETFs has launched the Defiance Daily Target 2X Long SpaceX ETF (SPCU), offering leveraged exposure to SpaceX shares. Defiance's CIO Sylvia Jablonski emphasizes that investors often mistakenly view SpaceX solely as a rocket company, overlooki...

Market News
Bullish
55 minutes ago
SpyGlass Pharma appoints Shannon Treviño as general counsel to support Phase 3 trials and commercialization plans.

SpyGlass Pharma appoints Shannon Treviño as general counsel to support Phase 3 trials and commercialization plans.

SpyGlass Pharma has named Shannon Treviño as its new general counsel. Treviño brings extensive legal and leadership experience, having previously guided Inari Medical through a $4.9 billion acquisition. Her appointment comes as SpyGlass advances its ...

Company Fundamentals
Bullish
1 hour ago
Navacaprant fails Phase 3 trials; Neumora halts its development, focusing on other drug candidates.

Navacaprant fails Phase 3 trials; Neumora halts its development, focusing on other drug candidates.

Neumora Therapeutics announced that its Phase 3 KOASTAL-2 and -3 trials for navacaprant, a treatment for major depressive disorder, did not meet primary or key secondary endpoints, leading to discontinuation of navacaprant's development. Despite this...

Company Fundamentals
Bearish
1 hour ago
Ouster stock jumps nearly 8% on expanded manufacturing deal with Benchmark Electronics

Ouster stock jumps nearly 8% on expanded manufacturing deal with Benchmark Electronics

Ouster's stock surged nearly 8% in premarket trading after expanding its manufacturing partnership with Benchmark Electronics to scale production of its new REV8 digital lidar sensors. The REV8 sensors target industrial, robotics, automotive, and sma...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App